Clipping of news on Brazilian Culture, Law and Citizenship
 


Health

Idec asks suspension of the sale of sibutramine in Brazil

27/1/2010

This article was translated by an automatic translation system, and was therefore not reviewed by people.




Idec has today (26) a letter to the National Health Surveillance Agency (Anvisa) requesting immediate interim prohibition of drugs of sibutramine, a substance used for weight loss that, according to new studies, increases the risk of heart attack and stroke.

As widely reported, the European Medicines Agency (EMEA) has banned the sale of the drug, because concluded that the benefits of sibutramine did not outweigh the risks involved in consumption.

Studies by the EMEA showed that substance use increases the chance of occurrence of cardiovascular diseases, particularly heart attack and stroke.
The characteristics of the population to which the product is used - obese - makes the situation more serious, since obesity is a factor of increased risk of cardiovascular disease.

Second report of the Board International Narcotics Control Board (INCB), an agency of the United Nations, Brazil is the country that consumes diet pills in the world.

Given the facts, Idec believes that the suspension of sale of Sibutramine in the country is essential to enforce the right to health and the precautionary principle.


Source: Portal Idec


 

This article was translated by an automatic translation system, and was therefore not reviewed by people.

Important:
The JurisWay site does not interfere in the work provided by doctrine, why only reflect the opinions, ideas and concepts of their authors.


  Subjects list
 
  Copyright (c) 2006-2009. JurisWay - All rights reserved.